GSK2202083A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK2202083A, covering 2014-08-15 to 2017-04-11. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose [Phase 2]